Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Cannabis Withdrawal: early-phase trial registry

1 of 3 indexed Cannabis Withdrawal trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Cannabis Withdrawal: 3 US clinical trials tracked, 1 recruiting.

Cannabis Withdrawal is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Vermont, running 1 of these trials.

Enrollment posture brief

Registry condition cannabis-withdrawal

OPEN 1 | RECR 33% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Cannabis Withdrawal (this)33%
Open-enrollment share among volume-matched conditions near Cannabis Withdrawal

Cannabis Withdrawal lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cannabis Withdrawal on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cannabis Withdrawal is recruiting below its size-band peers.

    1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Cannabis Withdrawal records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

T-Break Guide Behavioral
1 trials
Elastic Net Regression Device
1 trials
Progesterone Drug
1 trials
Contingency Management Behavioral
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Cannabis Withdrawal trials. A trial with sites in several states counts in each.

Vermont 1 trials
South Carolina 1 trials
Indiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cannabis Withdrawal page

3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cannabis Withdrawal condition card totals 3 registered trials; most-linked intervention T-Break Guide; top US site state Vermont. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.